James Thomson
đ€ SpeakerAppearances Over Time
Podcast Appearances
Drug development cycles are long.
Patient treatment cycles are long.
it'll take a while for this company to restore itself to its former glory.
And I'm not entirely convinced at the moment that they know how to do that.
They keep just saying, well, everything's basically okay.
No, there's a fundamentally decent business.
They are â this business in America where they turn â
They collect blood.
They turn it into plasma products for the treatment of kidney diseases and other rare diseases.
I've said that wrong.
Thank you, Alan.
That is a good business.
No doubt about it.
It's a sector that CSL created.
But this is the sort of shame of it.
CSL was dominant, still is the largest producer and has the largest global market share.
But they're now the number three in America, which is the key market.